Marc Beer is the co-founder and CEO of Renovia Inc. and the former CEO of Aegerion Pharmaceuticals. Under his leadership at Renovia, he has done a great deal of work in helping this company to attain unprecedented growth in just two years. In 2018, the company closed the second funding series making it one of the most promising med-tech startups in the United States.
Series B Funding
Renovia Inc. has received $42.3 million in Series B Funding round. The deal was closed in 2018 and facilitated by CEO Marc Beer. The funds will go towards creating new products to treat and diagnose pelvic floor disorders. The funds were received through Series B equity which brought $32.3 million and a venture debt which brought $10 million.
Renovia, a Boston-based med-tech startup, is creating products that will eliminate pelvic floor disorders such as urinary incontinence. It is estimated that over $250 million women worldwide are affected by pelvic floor disorders. In April 2018, the first product from Renovia was approved by the FDA. It is known as the Leva digital health system. It is a product that will help women top engage in the exercises in the right way.
Renovia Inc. has a promising future and has attracted the attention of notable investors. The Longwood, a renowned healthcare investor in the United States, is one of the companies that came through during the Series B funding. Marc Beer is happy with the progress that has been seen in the first two years of operations. The fact that many investors are willing to support them is an indication of great days ahead.
Renovia Inc. is utilizing the possibilities of technology to create a product that provides women with the necessary data needed to treat and diagnose pelvic disorders. Women will now have access to more data that will guide them when engaging in floor strengthening exercises. The ultimate goal of this firm is to create low-cost technology that is affordable by all women.
Marc Beer is the force to reckon with in this company. He is the person behind much of the success that Renovia has recorded in the past two years. His track record in various sector of the healthcare industry is remarkable. With the various organizations that he has worked with, he has left a great legacy. While working with ViaCell, he made the company to record its best performance ever. It employed 300 workers and became a public com[any. Marc Beer holds a degree from the University of Miami.
Under his leadership, Renovia is expected to make a mark as the fastest growing med-tech startup in the United States. His experience, skills, and determination make him one of the best-performing executives. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html